1 – 10 of 659
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Real-world experiences of adult individuals or caregivers of children who received teplizumab treatment in stage 2 type 1 diabetes
- Contribution to journal › Article
-
Mark
Mild or moderate hemophilia is not always a mild or moderate bleeding disorder : Back to the clinical phenotype
- Contribution to journal › Article
-
Mark
Evaluation of kidney function and damage in patients with hemophilia B—insights from the B-Natural study
- Contribution to journal › Article
-
Mark
Haemophilia B : an illustrative review of current challenges and opportunities
- Contribution to journal › Article
-
Mark
Health-Related Quality of Life, Physical Activity and Joint Health in People With Severe Haemophilia A Receiving Emicizumab : Results From the Phase IV HemiNorth 2 Study
- Contribution to journal › Article
-
Mark
Comorbidity and Mortality in Men and Women With Haemophilia in Three Nordic Countries–Comparisons to Matched Controls
- Contribution to journal › Article
-
Mark
A plain language summary on indirectly comparing bleeding after valoctocogene roxaparvovec gene therapy to bleeding with emicizumab prophylaxis
- Contribution to journal › Article
-
Mark
Nya klassifikationskriterier för antifosfolipidsyndrom
- Contribution to journal › Article
-
Mark
Risk of new-onset type 1 diabetes in individuals with celiac disease and thyroid disease—An observational study
- Contribution to journal › Article
-
Mark
Dronedarone vs Sotalol Among Patients With Atrial Fibrillation : A Meta-Analysis of Retrospective Observational Databases
- Contribution to journal › Article
